239 related articles for article (PubMed ID: 32849498)
1. Beneficial Effect of Antibiotics and Microbial Metabolites on Expanded Vδ2Vγ9 T Cells in Hepatocellular Carcinoma Immunotherapy.
Han J; Zhang S; Xu Y; Pang Y; Zhang X; Hu Y; Chen H; Chen W; Zhang J; He W
Front Immunol; 2020; 11():1380. PubMed ID: 32849498
[TBL] [Abstract][Full Text] [Related]
2. Tandem-epitope peptide: a novel stimulator for gammadeltaT cells in tumor immunotherapy.
He X; Chen H; Wu D; Cui L; He W
Cancer Lett; 2010 Feb; 288(1):86-93. PubMed ID: 19665289
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy.
Sato K; Kimura S; Segawa H; Yokota A; Matsumoto S; Kuroda J; Nogawa M; Yuasa T; Kiyono Y; Wada H; Maekawa T
Int J Cancer; 2005 Aug; 116(1):94-9. PubMed ID: 15756684
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.
Sethi V; Kurtom S; Tarique M; Lavania S; Malchiodi Z; Hellmund L; Zhang L; Sharma U; Giri B; Garg B; Ferrantella A; Vickers SM; Banerjee S; Dawra R; Roy S; Ramakrishnan S; Saluja A; Dudeja V
Gastroenterology; 2018 Jul; 155(1):33-37.e6. PubMed ID: 29630898
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models.
Strati F; Pujolassos M; Burrello C; Giuffrè MR; Lattanzi G; Caprioli F; Troisi J; Facciotti F
Microbiome; 2021 Feb; 9(1):39. PubMed ID: 33549144
[TBL] [Abstract][Full Text] [Related]
7. Identification of new potential antigen recognized by γδT cells in hepatocellular carcinoma.
Xi X; Guo Y; Zhu M; Qiu F; Lei F; Li G; Du B
Cancer Immunol Immunother; 2021 Jul; 70(7):1917-1927. PubMed ID: 33399933
[TBL] [Abstract][Full Text] [Related]
8. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
[TBL] [Abstract][Full Text] [Related]
9. The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner.
Li F; Hao X; Chen Y; Bai L; Gao X; Lian Z; Wei H; Sun R; Tian Z
Nat Commun; 2017 Jan; 7():13839. PubMed ID: 28067223
[TBL] [Abstract][Full Text] [Related]
10. Role of γδT cells in liver diseases and its relationship with intestinal microbiota.
Zhou QH; Wu FT; Pang LT; Zhang TB; Chen Z
World J Gastroenterol; 2020 May; 26(20):2559-2569. PubMed ID: 32523311
[TBL] [Abstract][Full Text] [Related]
11. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
[TBL] [Abstract][Full Text] [Related]
12. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells.
Benakis C; Brea D; Caballero S; Faraco G; Moore J; Murphy M; Sita G; Racchumi G; Ling L; Pamer EG; Iadecola C; Anrather J
Nat Med; 2016 May; 22(5):516-23. PubMed ID: 27019327
[TBL] [Abstract][Full Text] [Related]
13. Wnt pathway activator TWS119 enhances the proliferation and cytolytic activity of human γδT cells against colon cancer.
Chen YQ; Zheng L; Aldarouish M; Zhou ZH; Pan N; Liu JQ; Chen FX; Wang LX
Exp Cell Res; 2018 Jan; 362(1):63-71. PubMed ID: 29104081
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics-induced gut microbiota dysbiosis promotes tumor initiation via affecting APC-Th1 development in mice.
Xu C; Ruan B; Jiang Y; Xue T; Wang Z; Lu H; Wei M; Wang S; Ye Z; Zhai D; Wang L; Lu Z
Biochem Biophys Res Commun; 2017 Jun; 488(2):418-424. PubMed ID: 28506830
[TBL] [Abstract][Full Text] [Related]
15. Influence of changes in the intestinal microflora on the immune function in mice.
Kishida S; Kato-Mori Y; Hagiwara K
J Vet Med Sci; 2018 Mar; 80(3):440-446. PubMed ID: 29415902
[TBL] [Abstract][Full Text] [Related]
16. The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors.
Joachim L; Göttert S; Sax A; Steiger K; Neuhaus K; Heinrich P; Fan K; Orberg ET; Kleigrewe K; Ruland J; Bassermann F; Herr W; Posch C; Heidegger S; Poeck H
EBioMedicine; 2023 Nov; 97():104834. PubMed ID: 37865045
[TBL] [Abstract][Full Text] [Related]
17. Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules.
Troye-Blomberg M; Worku S; Tangteerawatana P; Jamshaid R; Söderström K; Elghazali G; Moretta L; Hammarström M; Mincheva-Nilsson L
Scand J Immunol; 1999 Dec; 50(6):642-50. PubMed ID: 10607313
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection.
Rey K; Manku S; Enns W; Van Rossum T; Bushell K; Morin RD; Brinkman FSL; Choy JC
Transplantation; 2018 Jul; 102(7):1085-1095. PubMed ID: 29538261
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes.
Chen J; Niu H; He W; Ba D
Int Arch Allergy Immunol; 2001 Jul; 125(3):256-63. PubMed ID: 11490159
[TBL] [Abstract][Full Text] [Related]
20. Human γδT-cell subsets and their involvement in tumor immunity.
Wu D; Wu P; Qiu F; Wei Q; Huang J
Cell Mol Immunol; 2017 Mar; 14(3):245-253. PubMed ID: 27890919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
